Wei Han
Second Affiliated Hospital of Nanjing Medical University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Polyomavirus and related diseases, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation(2005)510 cited
- → Who is the best donor for a related HLA haplotype-mismatched transplant?(2014)352 cited
- → MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial(2013)322 cited
- → Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation(2009)292 cited
- → Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation(2012)289 cited
- → Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets